- Home
- CRVS vs NODK Comparison
CRVS vs NODK Comparison
Compare CRVS & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- NODK
- Stock Information
- Founded
- CRVS 2014
- NODK 1946
- Country
- CRVS United States
- NODK United States
- Employees
- CRVS 31
- NODK N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- NODK Property-Casualty Insurers
- Sector
- CRVS Health Care
- NODK Finance
- Exchange
- CRVS Nasdaq
- NODK Nasdaq
- Market Cap
- CRVS 328.5M
- NODK 261.8M
- IPO Year
- CRVS 2016
- NODK 2017
- Fundamental
- Price
- CRVS $3.92
- NODK $12.43
- Analyst Decision
- CRVS Strong Buy
- NODK
- Analyst Count
- CRVS 4
- NODK 0
- Target Price
- CRVS $15.00
- NODK N/A
- AVG Volume (30 Days)
- CRVS 786.0K
- NODK 17.0K
- Earning Date
- CRVS 08-05-2025
- NODK 08-07-2025
- Dividend Yield
- CRVS N/A
- NODK N/A
- EPS Growth
- CRVS N/A
- NODK N/A
- EPS
- CRVS N/A
- NODK N/A
- Revenue
- CRVS N/A
- NODK $322,139,000.00
- Revenue This Year
- CRVS N/A
- NODK N/A
- Revenue Next Year
- CRVS N/A
- NODK N/A
- P/E Ratio
- CRVS N/A
- NODK $42.60
- Revenue Growth
- CRVS N/A
- NODK 3.15
- 52 Week Low
- CRVS $1.75
- NODK $12.01
- 52 Week High
- CRVS $10.00
- NODK $17.24
- Technical
- Relative Strength Index (RSI)
- CRVS 49.54
- NODK 42.57
- Support Level
- CRVS $3.83
- NODK $12.08
- Resistance Level
- CRVS $4.33
- NODK $13.33
- Average True Range (ATR)
- CRVS 0.28
- NODK 0.47
- MACD
- CRVS -0.03
- NODK -0.04
- Stochastic Oscillator
- CRVS 21.74
- NODK 26.38
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About NODK NI Holdings Inc.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.